| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1829 |
| Trial ID | NCT03366324 |
| Disease | Acute Lymphoblastic Leukemia | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies |
| Year | 2016 |
| Country | China |
| Company sponsor | Wuhan Sian Medical Technology Co., Ltd |
| Other ID(s) | CART-CD19-03 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||